Effect of Glossopharyngeal Versus Diaphragmatic Breathing Exercise on Pulmonary Function After Decortication Surgery

Not Applicable

Not yet recruiting

• Conditions: Pulmonary Disease
• Interventions: Other: traditional chest techniques; Other: Glossopharyngeal breathing exercise; Other: Diaphragmatic breathing exercise

• Registration Number: NCT06518759
• Lead Sponsor: Cairo University

Brief Summary

This study will be conducted to compare between the effect of glossopharyngeal and diaphragmatic breathing exercises on pulmonary functions after decortication surgery

Detailed Description

Lung decortication is a well-known procedure for the treatment of empyema. Persistent lung collapse and non-expansion of the lung parenchyma are frequently noticed in the postoperative period after decortications, chest physiotherapy plays a crucial role in the re-expansion of underlying parenchyma.

There is an increased flow of patients after decortication surgery to hospitals who suffer from decreased lung volumes so the hospitalization period for them increases which puts an economical burden on health insurance services with a decreased level of quality of life that is the most concern to improve patient status and relieve this burden. So this study aims to improve patient's lung volumes and arterial blood gas parameters which improves patient status through two various forms of breathing exercises.

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Status Verified: 2024-07
• Study Start: 2024-07
• Study First Submitted: 2024-07-17
• Study First Submitted QC: 2024-07-22
• Last Update Submitted: 2024-07-22
• Study First Posted: 2024-07-24
• Last Update Posted: 2024-07-24
• Primary Completion: 2024-09
• Study Completion: 2024-10

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• The participant's body mass index (BMI) will be ranged from 25- 29.9 kg/m2
• The patient will receive treatment after 24 hours after decortication
• The study will be in the intensive care unit (ICU).
• The patients have unilateral lung decortication
• Their vital capacity is 70% or less.

Read More

Exclusion Criteria

• Cancerous patient.
• Inability to comprehend and follow instructions as in dementia
• paralytic involvement of thorax muscle
• Abdominal diseases that affect diaphragmatic function
• Diaphragmatic paralysis

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Traditional chest techniques +Glossopharyngeal breathing exercise	traditional chest techniques	the patients will receive traditional chest techniques and glossopharyngeal breathing exercise
Traditional chest techniques +diaphragmatic breathing exercise	traditional chest techniques	the patients will receive traditional chest techniques and diaphragmatic breathing exercise
Traditional chest techniques	traditional chest techniques	the patients will receive traditional chest techniques only
Traditional chest techniques +Glossopharyngeal breathing exercise	Glossopharyngeal breathing exercise	the patients will receive traditional chest techniques and glossopharyngeal breathing exercise
Traditional chest techniques +diaphragmatic breathing exercise	Diaphragmatic breathing exercise	the patients will receive traditional chest techniques and diaphragmatic breathing exercise

Primary Outcome Measures

Name	Time	Method
Tidal volume	within 2 weeks	The spirometer device (Meditech, made in China) will be used to measure tidal volume for all participants in all groups before and after the treatment program. It is the amount of air that moves in or out of the lungs with each respiratory cycle. It measures about 400 ml in a healthy female.
Measurement of the partial arterial pressure of oxygen (PaO2)	within 2 weeks	Blood gas analyzer will be used to measure the partial arterial pressure of oxygen (PaO2)for all participants in all groups before and after the treatment program.; The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device.; the normative value of Pao2 is 1.7-13.3 KPa.
Inspiratory reserve volume (IRV)	within 2 weeks	The spirometer device (Meditech, made in China) will be used to measure inspiratory reserve volume (IRV) for all participants in all groups before and after the treatment program.; - IRV: It is the amount of air that can be forcibly inhaled after normal tidal volume. The normal adult value is 1900-3300 ml.
Measurement of oxygen saturation (SO2)	within 2 weeks	Blood gas analyzer will be used to measure oxygen saturation (SO2) for all participants in all groups before and after the treatment program.; The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device.; The normative value of SO2 is 95-100%..
Expiratory reserve volume (ERV)	within 2 weeks	The spirometer device (Meditech, made in China) will be used to measure expiratory reserve volume (ERV) for all participants in all groups before and after the treatment program.; ERV: It is the amount of extra air above normal breath-exhaled during forceful breath out, its average is about 800ml in females.
Measurement of the potential of hydrogen (PH)	within 2 weeks	Blood gas analyzer will be used to measure the potential of hydrogen (PH) for all participants in all groups before and after the treatment program.; The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device.; The normative value of pH is7.35-7.45
Measurement of the Bicarbonate (HCO3)	within 2 weeks	Blood gas analyzer will be used to measure the Bicarbonate (HCO3) for all participants in all groups before and after the treatment program.; The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device.; The normative value of HCO3 is 22-26 mmol/L.
Measurement of the partial arterial pressure of carbon dioxide(PaCO2)	within 2 weeks	Blood gas analyzer will be used to measure the partial arterial pressure of carbon dioxide(PaCO2) for all participants in all groups before and after the treatment program.; The blood sample was taken from the radial or brachial or femoral artery or from arterial catheter and put in the device.; the normative value of PaCO2 is 4.7-6 KPa.